JP2014509600A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014509600A5 JP2014509600A5 JP2013558409A JP2013558409A JP2014509600A5 JP 2014509600 A5 JP2014509600 A5 JP 2014509600A5 JP 2013558409 A JP2013558409 A JP 2013558409A JP 2013558409 A JP2013558409 A JP 2013558409A JP 2014509600 A5 JP2014509600 A5 JP 2014509600A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- carbocycle
- groups
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052717 sulfur Inorganic materials 0.000 claims description 39
- 125000003118 aryl group Chemical group 0.000 claims description 34
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 32
- 229910052760 oxygen Inorganic materials 0.000 claims description 28
- 125000001424 substituent group Chemical group 0.000 claims description 28
- 229910052799 carbon Inorganic materials 0.000 claims description 26
- 125000000623 heterocyclic group Chemical group 0.000 claims description 25
- 125000001072 heteroaryl group Chemical group 0.000 claims description 24
- 125000005842 heteroatom Chemical group 0.000 claims description 23
- 150000001875 compounds Chemical class 0.000 claims description 20
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 16
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims description 13
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- -1 heterocyclyl-O— Chemical group 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 8
- 125000002837 carbocyclic group Chemical group 0.000 claims description 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 125000001624 naphthyl group Chemical group 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 6
- 125000000304 alkynyl group Chemical group 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 102100033839 Glucose-dependent insulinotropic receptor Human genes 0.000 claims description 2
- 101000996752 Homo sapiens Glucose-dependent insulinotropic receptor Proteins 0.000 claims description 2
- 230000004913 activation Effects 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 125000001153 fluoro group Chemical group F* 0.000 claims description 2
- 230000001404 mediated effect Effects 0.000 claims description 2
- 238000000034 method Methods 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- UOKJXEROSWBCHJ-UHFFFAOYSA-N 3-fluoro-4-(tetrazol-1-yl)benzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1N1N=NN=C1 UOKJXEROSWBCHJ-UHFFFAOYSA-N 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11158114.6 | 2011-03-14 | ||
| EP11158114 | 2011-03-14 | ||
| PCT/EP2012/054376 WO2012123449A1 (en) | 2011-03-14 | 2012-03-13 | N- cyclopropyl - n- piperidinylbenzamides as gpr119 modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014509600A JP2014509600A (ja) | 2014-04-21 |
| JP2014509600A5 true JP2014509600A5 (cg-RX-API-DMAC7.html) | 2015-04-30 |
| JP5935154B2 JP5935154B2 (ja) | 2016-06-15 |
Family
ID=45812800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013558409A Active JP5935154B2 (ja) | 2011-03-14 | 2012-03-13 | Ｇｐｒ１１９モジュレーターとしてのｎ−シクロプロピル−ｎ−ピペリジニルベンズアミド |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8822471B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2686312B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5935154B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012123449A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012530758A (ja) | 2009-06-24 | 2012-12-06 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規化合物、医薬組成物及びそれに関する方法 |
| UY33805A (es) | 2010-12-17 | 2012-07-31 | Boehringer Ingelheim Int | ?Derivados de dihidrobenzofuranil-piperidinilo, aza-dihidrobenzofuranilpiperidinilo y diaza-dihidrobenzofuranil-piperidinilo, composiciones farmacéuticas que los contienen y usos de los mismos?. |
| US8822471B2 (en) | 2011-03-14 | 2014-09-02 | Boehringer Ingelheim International Gmbh | Compounds, pharmaceutical compositions and uses thereof |
| JP6094578B2 (ja) | 2011-06-09 | 2017-03-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 代謝性障害の治療のためのｇｐｒ１１９モジュレーターとしての置換ピペリジン |
| AU2013290100A1 (en) | 2012-07-11 | 2015-01-29 | Elcelyx Therapeutics, Inc. | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk |
| JP2015523404A (ja) * | 2012-08-02 | 2015-08-13 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｎ−シクロプロピル−ｎ−ピペリジニル−アミド、これらを含有する医薬組成物およびその使用 |
| US9682966B2 (en) * | 2012-08-16 | 2017-06-20 | The Scripps Research Institute | Kappa opioid ligands |
| EP2892888B1 (en) * | 2012-09-10 | 2018-04-18 | Boehringer Ingelheim International GmbH | N-cyclopropyl-n-piperidinyl-amides, pharmaceutical compositions containing them, and uses thereof |
| WO2016138631A1 (en) | 2015-03-03 | 2016-09-09 | Eli Lilly And Company | Imidazo benzamide compounds |
| US11970486B2 (en) | 2016-10-24 | 2024-04-30 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
| CN110392833A (zh) | 2017-01-06 | 2019-10-29 | 优曼尼蒂治疗公司 | 治疗神经病症的方法 |
| WO2019084157A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES THEREOF |
| AU2019238326B2 (en) | 2018-03-23 | 2025-03-06 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
| MA54829A (fr) | 2019-01-24 | 2021-12-01 | Yumanity Therapeutics Inc | Composés et leurs utilisations |
| EA202192047A1 (ru) | 2019-11-13 | 2021-12-08 | Юманити Терапьютикс, Инк. | Соединения и их применение |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI326214B (en) * | 2002-07-17 | 2010-06-21 | Avanir Pharmaceuticals Inc | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| EP1559428A4 (en) | 2002-11-06 | 2008-08-20 | Takeda Pharmaceutical | RECEIVER REGULATOR |
| JP2008537953A (ja) | 2005-04-15 | 2008-10-02 | エラン ファーマシューティカルズ，インコーポレイテッド | ブラジキニンｂ１受容体拮抗作用に有用な新規化合物 |
| US8039458B2 (en) | 2005-11-17 | 2011-10-18 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| TW200815377A (en) * | 2006-04-24 | 2008-04-01 | Astellas Pharma Inc | Oxadiazolidinedione compound |
| ES2349887T3 (es) * | 2006-06-08 | 2011-01-12 | Amgen Inc. | Derivados de benzamida y usos relacionados con los mismos. |
| DE102006035927A1 (de) * | 2006-07-31 | 2008-02-14 | Drei-S-Werk Präzisionswerkzeuge GmbH & Co Fertigungs-KG | Werkzeugsstift für eine Werkzeugform sowie Verfahren zum Herstellen eines solchen Werkzeugstifts |
| AU2007291254A1 (en) * | 2006-08-30 | 2008-03-06 | Inovacia Ab | Pyrimidine compounds for treating GPR119 related disorders |
| EP1903038A1 (de) * | 2006-09-07 | 2008-03-26 | Bayer Schering Pharma Aktiengesellschaft | N-(1-Hetaryl-piperidin-4-yl)-(het)arylamide als EP2-Rezeptor Modulatoren |
| JP2010520878A (ja) * | 2007-03-08 | 2010-06-17 | アイアールエム・リミテッド・ライアビリティ・カンパニー | Ｇｐｒ１１９活性の調節剤としての化合物および組成物 |
| WO2008123992A1 (en) * | 2007-04-09 | 2008-10-16 | Tagnos, Inc. | Tag based knowledge system and methods for healthcare enterprises |
| NZ582661A (en) * | 2007-07-17 | 2012-03-30 | Bristol Myers Squibb Co | Method for modulating gpr119 g protein-coupled receptor and selected compounds |
| EP2297129B1 (en) * | 2008-04-14 | 2013-07-24 | Merck Sharp & Dohme Corp. | Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment |
| CN102203074A (zh) * | 2008-06-20 | 2011-09-28 | 麦它波莱克斯股份有限公司 | 芳基gpr119激动剂及其用途 |
| GB0812649D0 (en) * | 2008-07-10 | 2008-08-20 | Prosidion Ltd | Compounds |
| GB0812648D0 (en) * | 2008-07-10 | 2008-08-20 | Prosidion Ltd | Compounds |
| WO2010048149A2 (en) * | 2008-10-20 | 2010-04-29 | Kalypsys, Inc. | Heterocyclic modulators of gpr119 for treatment of disease |
| WO2010088518A2 (en) * | 2009-01-31 | 2010-08-05 | Kalypsys, Inc. | Heterocyclic modulators of gpr119 for treatment of disease |
| EA201200046A1 (ru) | 2009-06-24 | 2012-08-30 | Бёрингер Ингельхайм Интернациональ Гмбх | Новые соединения, фармацевтическая композиция и связанные с ними способы |
| JP2012530758A (ja) | 2009-06-24 | 2012-12-06 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規化合物、医薬組成物及びそれに関する方法 |
| WO2011138427A2 (en) | 2010-05-07 | 2011-11-10 | Boehringer Ingelheim International Gmbh | Pyridazinones as gpr119 agonists |
| UY33805A (es) | 2010-12-17 | 2012-07-31 | Boehringer Ingelheim Int | ?Derivados de dihidrobenzofuranil-piperidinilo, aza-dihidrobenzofuranilpiperidinilo y diaza-dihidrobenzofuranil-piperidinilo, composiciones farmacéuticas que los contienen y usos de los mismos?. |
| MX2013008083A (es) | 2011-01-21 | 2013-09-13 | Boehringer Ingelheim Int | Dihidrofuranos fusionados como moduladores de gpr119 para el tratamiento de diabetes, obesidad y trastornos relacionados. |
| US8822471B2 (en) | 2011-03-14 | 2014-09-02 | Boehringer Ingelheim International Gmbh | Compounds, pharmaceutical compositions and uses thereof |
| JP6094578B2 (ja) | 2011-06-09 | 2017-03-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 代謝性障害の治療のためのｇｐｒ１１９モジュレーターとしての置換ピペリジン |
-
2012
- 2012-03-13 US US13/418,376 patent/US8822471B2/en active Active
- 2012-03-13 JP JP2013558409A patent/JP5935154B2/ja active Active
- 2012-03-13 EP EP12708044.8A patent/EP2686312B1/en active Active
- 2012-03-13 WO PCT/EP2012/054376 patent/WO2012123449A1/en not_active Ceased